Abstract:The ongoing COVID-19 pandemic has caused dramatic loss of human life. There is an urgent need for safe and efficient anti-coronavirus infection drugs. Anti-coronavirus peptides (ACovPs) can inhibit coronavirus infection. With high-efficiency, low-toxicity, and broad-spectrum inhibitory effects on coronaviruses, they are promising candidates to be developed into a new type of anti-coronavirus drug. Experiment is the traditional way of ACovPs' identification, which is less efficient and more expensive. With the accumulation of experimental data on ACovPs, computational prediction provides a cheaper and faster way to find anti-coronavirus peptides' candidates. In this study, we ensemble several state-of-the-art machine learning methodologies to build nine classification models for the prediction of ACovPs. These models were pre-trained using deep neural networks, and the performance of our ensemble model, ACP-Dnnel, was evaluated across three datasets and independent dataset. We followed Chou's 5-step rules. (1) we constructed the benchmark datasets data1, data2, and data3 for training and testing, and introduced the independent validation dataset ACVP-M; (2) we analyzed the peptides sequence composition feature of the benchmark dataset; (3) we constructed the ACP-Dnnel model with deep convolutional neural network (DCNN) merged the bi-directional long short-term memory (BiLSTM) as the base model for pre-training to extract the features embedded in the benchmark dataset, and then, nine classification algorithms were introduced to ensemble together for classification prediction and voting together; (4) tenfold cross-validation was introduced during the training process, and the final model performance was evaluated; (5) finally, we constructed a user-friendly web server accessible to the public at http://150.158.148.228:5000/ . The highest accuracy (ACC) of ACP-Dnnel reaches 97%, and the Matthew's correlation coefficient (MCC) value exceeds 0.9. On three different datasets, its average accuracy is 96.0%. After the latest independent dataset validation, ACP-Dnnel improved at MCC, SP, and ACC values 6.2%, 7.5% and 6.3% greater, respectively. It is suggested that ACP-Dnnel can be helpful for the laboratory identification of ACovPs, speeding up the anti-coronavirus peptide drug discovery and development. We constructed the web server of anti-coronavirus peptides' prediction and it is available at http://150.158.148.228:5000/ .

Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

A Database of Anti-Coronavirus Peptides.

ACVPICPred: inhibitory activity prediction of anti-coronavirus peptides based on artificial neural network

EACVP: An ESM-2 LM Framework Combined CNN and CBAM Attention to Predict Anti-coronavirus Peptides

Generative Adversarial Network-Based Data Augmentation Method for Anti-coronavirus Peptides Prediction.

ACP-Dnnel: anti-coronavirus peptides' prediction based on deep neural network ensemble learning

ACVPred: Enhanced prediction of anti-coronavirus peptides by transfer learning combined with data augmentation

A Survey on Computational Methods in Discovering Protein Inhibitors of SARS-CoV-2

CoronaPep: an Anti-Coronavirus Peptide Generation Tool.

Recent Advances in the Exploration and Discovery of SARS-CoV-2 Inhibitory Peptides from Edible Animal Proteins

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides

PACVP: Prediction of Anti-Coronavirus Peptides Using a Stacking Learning Strategy with Effective Feature Representation

iDVEIP: A computer‐aided approach for the prediction of viral entry inhibitory peptides

Peptide-based inhibitors hold great promise as the broad-spectrum agents against coronavirus

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery

AntiCVP-Deep: Identify Anti-Coronavirus Peptides Between Different Negative Datasets Based on Self-Attention and Deep Learning

Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients

Research Progress on Active Compounds Against Pathogenic Coronaviruses and Their Potential Target Proteins

Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery

FEOpti-ACVP: identification of novel anti-coronavirus peptide sequences based on feature engineering and optimization